Mechanism of Action for Xaluritamig

Xaluritamig is a novel T-cell engager immunotherapy being developed for advanced prostate cancer. Xaluritamig is designed to activate the immune system against prostate cancer cells by creating an immune synapse between immune T cells and STEAP1, a protein that is uniquely overexpressed in prostate cancer cells.^1-3



Watch this video to learn more about the mechanism of action of Xaluritamig.